Srinivasan Sangeetha, Raman Rajiv, Ganesan Suganeswari, Roy Rupak, Natarajan Viswanathan, Sharma Tarun
Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Department of Preventive Ophthalmology, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Indian J Ophthalmol. 2017 Jul;65(7):589-595. doi: 10.4103/ijo.IJO_520_16.
The aim of this study is to investigate the 4-year incidence and progression of visual impairment (VI) and the associated risk factors for incident VI in a South Indian population with type 2 diabetes.
A total of 634 participants with type 2 diabetes were found eligible after 4 years. Visual acuity (VA) was estimated using the modified Early Treatment Diabetic Retinopathy Study protocol. VA in the better eye was considered for the assessment of VI based on the World Health Organization criteria. Mild VI was defined as VA <20/40 but up to 20/60, moderate VI as VA <20/60 but up to 20/200, severe VI as VA <20/200 but up to 10/200, and blindness as VA worse than 10/200.
The 4-year incidence of any VI, mild VI, moderate VI, severe VI, and blindness was 21.7%, 18.3%, 3.4%, 0.0%, and 0.0%, respectively; of the 13 participants with VI at baseline, 12 (92%) showed worsening/progression of VI on follow-up. Multiple logistic regression showed that nuclear cataract of grades >4.0 (odds ratio [OR]: 2.612 [1.148-5.942], P = 0.022) and lower socioeconomic score (OR: 0.965 [95% confidence interval, (0.933-0.998)], P = 0.040) were associated with the risk of future incident VI. Refractive error (47%) and cataract (30%) were identified as the leading causes of incident VI at follow-up.
VI seems to be a significant problem among diabetic participants in the South Indian population. Refractive error and cataract are the leading but treatable causes of incident VI in this population and would benefit from intervention.
本研究旨在调查南印度2型糖尿病患者4年期间视力损害(VI)的发生率、进展情况以及新发VI的相关危险因素。
4年后共634名2型糖尿病参与者符合条件。采用改良的糖尿病视网膜病变早期治疗研究方案评估视力(VA)。根据世界卫生组织标准,以较好眼的VA评估VI。轻度VI定义为VA<20/40但≥20/60,中度VI为VA<20/60但≥20/200,重度VI为VA<20/200但≥10/200,失明为VA低于10/200。
任何VI、轻度VI、中度VI、重度VI和失明的4年发生率分别为21.7%、18.3%、3.4%、0.0%和0.0%;基线时有VI的13名参与者中,12名(92%)在随访时VI出现恶化/进展。多因素logistic回归显示,核性白内障分级>4.0(比值比[OR]:2.612[1.148 - 5.942],P = 0.022)和社会经济得分较低(OR:0.965[95%置信区间,(0.933 - 0.998)],P = 0.040)与未来新发VI的风险相关。屈光不正(47%)和白内障(30%)被确定为随访时新发VI的主要原因。
在南印度人群的糖尿病参与者中,VI似乎是一个严重问题。屈光不正和白内障是该人群新发VI的主要但可治疗的原因,干预可能有益。